Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection

Virology

Volumn 257, Issue 1, 1999, Pages 106-118

  Grieder, Franziska B ^a   Vogel, Stefanie N ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ALPHA VIRUS; ANIMAL EXPERIMENT; ARTICLE; CLEARANCE; EPIDEMIOLOGICAL DATA; HISTOPATHOLOGY; IMMUNE RESPONSE; INFECTION RISK; KNOCKOUT GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS INFECTION; VIRUS VIRULENCE;

EID: 0033602581     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9662     Document Type: Article

References (40)

1. Balter M. HIV's other immune-system targets: Macrophages [news]. Science. 274:1996;1464-1465.
2. Ben-Nathan D., Maestroni G. J., Lustig S., Conti A. Protective effects of melatonin in mice infected with encephalitis viruses. Arch. Virol. 140:1995;223-230.
3. Bose H. R., Sagik B. P. The virus envelope in cell attachment. J. Gen. Virol. 9:1970;159-161.
4. Bowen G. S. Experimental infection of North American mammals with epidemic Venezuelan encephalitis virus. Am. J. Trop. Med. Hyg. 25:1976;891-899.
5. Charles P. C., Brown K. W., Davis N. L., Hart M. K., Johnston R. E. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate. Virology. 228:1997;153-160.
6. Chebloune Y., Karr B. M., Raghavan R., Singh D. K., Leung K., Sheffer D., Pinson D., Foresman L., Narayan O. Neuroinvasion by ovine lentivirus in infected sheep mediated by inflammatory cells associated with experimental allergic encephalomyelitis. J. Neurovirol. 4:1998;38-48.
7. Coppenhaver D. H., Singh I. P., Sarzotti M., Levy H. B., Baron S. Treatment of intracranial alphavirus infections in mice by a combination of specific antibodies and an interferon inducer. Am. J. Trop. Med. Hyg. 52:1995;34-40.
8. Davis N. L., Brown K. W., Greenwald G. F., Zajac A. J., Zacny V. L., Smith J. F., Johnston R. E. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. Virology. 212:1995;102-110.
9. Davis N. L., Fuller F. J., Dougherty W. G., Olmsted R. A., Johnston R. E. A single nucleotide change in the E2 glycoprotein gene of Sindbis virus affects penetration rate in cell culture and virulence in neonatal mice. Proc. Natl. Acad. Sci. USA. 83:1986;6771-6775.
10. Davis N. L., Powell N., Greenwald G. F., Willis L. V., Johnson B. J., Smith J. F., Johnston R. E. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA clone. Virology. 183:1991;20-31.
11. Fujimura M., Tominaga T., Kato I., Takasawa S., Kawase M., Taniguchi T., Okamoto H., Yoshimoto T. Attenuation of nitric oxide synthase induction in IRF-1-deficient glial cells. Brain Res. 759:1997;247-250.
12. Fujita T., Reis L. F., Watanabe N., Kimura Y., Taniguchi T., Vilcek J. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl. Acad. Sci. USA. 86:1989;9936-9940.
13. Fujita T., Sakakibara J., Sudo Y., Miyamoto M., Kimura Y., Taniguchi T. Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO J. 7:1988;3397-3405.
14. Greenway T. E., Eldridge J. H., Ludwig G., Staas J. K., Smith J. F., Gilley R. M., Michalek S. M. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine. Vaccine. 13:1995;1411-1420.
15. Grieder F. B., Davis B. K., Zhou X. D., Chen S. J., Finkelman F. D., Gause W. C. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Virology. 233:1997;302-312.
16. Grieder F. B., Davis N. L., Aronson J. F., Sellon D. C., Suzuki K., Charles P. C., Johnston R. E. Specific restrictions in the progression of Venezuelan equine encephalitis virus induced disease resulting from single amino acid changes in the glycoprotein. Virology. 206:1995;994-1006.
17. Grieder F. B., Nguyen H. T. Virulent and attenuated mutant Venezuelan equine encephalitis virus show marked differences in replication in infection in murine macrophages. Microb. Pathog. 21:1996;85-95.
18. Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T., Taniguchi T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 58:1989;729-739.
19. Hart M. K., Pratt W., Panelo F., Tammariello R., Dertzbaugh M. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice. Vaccine. 15:1997;363-369.
20. Huprikar J., Dal Canto M. C., Rabinowitz S. G. Protection against lethal Venezuelan equine encephalitis (VEE) virus infection by cell-free supernatant obtained from immune spleen cells. J. Neurol. Sci. 97:1990;143-153.
21. Hwang S. Y., Hertzog P. J., Holland K. A., Sumarsono S. H., Tymms M. J., Hamilton J. A., Whitty G., Bertoncello I., Kola I. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. Natl. Acad. Sci. USA. 92:1995;11284-11288.
22. Jackson A., Sen Gupta S., Smith J. Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters. Vet. Pathol. 28:1991;410-418.
23. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Koh S. I., Kimura T., Green S. J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 263:1994;1612-1615.
24. Kimura T., Nakayama K., Penninger J., Kitagawa M., Harada H., Matsuyama T., Tanaka N., Kamijo R., Vilcek J., Mak T. W. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science. 264:1994;1921-1924.
25. Lehtonen A., Matikainen S., Jukunen I. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J. Immunol. 159:1997;794-803.
26. MacDonald, G. H. Davis, N. L. Johnston, R. E. 1997, Venezuelan equine encephalitis virus targets dendritic cells in the draining lymph node, In, Abstracts, American Society for Virology, 16th Annual Meeting, 172.
27. Matsuyama T., Kimura T., Kitagawa M., Pfeffer K., Kawakami T., Watanabe N., Kundig T. M., Amakawa R., Kishihara K., Wakeham A. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell. 75:1993;83-97.
28. Miyamoto M., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., Miyata T., Taniguchi T. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell. 54:1988;903-913.
29. Muller U., Steinhoff U., Reis L. F., Hemmi S., Pavlovic J., Zinkernagel R. M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 264:1994;1918-1921.
30. Nguyen H., Lin R., Hiscott J. Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins. Oncogene. 15:1997;1425-1435.
31. Pitha P. M. Reflections on the years in interferon research. J. Interferon Cytokine Res. 17:1997;181-184.
32. Pittman P. R., Makuch R. S., Mangiafico J. A., Cannon T. L., Gibbs P. H., Peters C. J. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine. 14:1996;337-343.
33. Rivas F., Diaz L. A., Cardenas V. M., Daza E., Bruzon L., Alcala A., De la Hoz O., Caceres F. M., Aristizabal G., Martinez J. W., Revelo D., De la Hoz F., Boshell J., Camacho T., Calderon L., Olano V. A., Villarreal L. I., Roselli D., Alvarez G., Ludwig G., Tsai T. Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J. Infect. Dis. 175:1997;828-832.
34. Rossi C. P., Delcroix M., Huitinga I., McAllister A., van Rooijen N., Claassen E., Brahic M. Role of macrophages during Theiler's virus infection. J. Virol. 71:1997;3336-3340.
35. Salkowski C. A., Barber S. A., Detore G. R., Vogel S. N. Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes. J. Immunol. 156:1996;3107-3110.
36. Strauss J. H., Strauss E. G. The alphaviruses: Gene expression, replication, and evolution. Microbiol. Rev. 58:1994;491-562.
37. Trgovcich J., Aronson J. F., Johnston R. E. Fatal Sindbis virus infection of neonatal mice in the absence of encephalitis. Virology. 224:1996;73-83.
38. Trgovcich J., Ryman K., Extrom P., Eldridge J. C., Aronson J. F., Johnston R. E. Sindbis virus infection of neonatal mice results in a severe stress response. Virology. 227:1997;234-238.
39. Victor J. S., D. G., Pollack A. D. The comparative pathology of Venezuelan equine encephalitis. J. Infect. Dis. 98:1956;55-66.
40. Watts D. M., Lavera V., Callahan J., Rossi C., Oberste M. S., Roehrig J. T., Cropp C. B., Karabatsos N., Smith J. F., Gubler D. J., Wooster M. T., Nelson W. M., Hayes C. G. Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Am. J. Trop. Med. Hyg. 56:1997;661-667.